BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24681730)

  • 1. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis.
    Liu Y; Liu T; Bao X; He M; Li L; Yang X
    Int J Gynecol Pathol; 2014 May; 33(3):218-24. PubMed ID: 24681730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
    Zhang H; Chen S; Niu G; Jiang H; Yao S
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
    Zhang HM; Chen SQ; Yao SZ
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing simultaneous positive expression of EZH2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
    Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
    Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
    Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
    Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome.
    Yang Y; Wu Q; Li N; Che S; Jin T; Nan Y; Lin Z; Chen L
    Hum Pathol; 2018 May; 75():179-188. PubMed ID: 29452216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
    Alshenawy HA
    Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.
    Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S
    BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAD2 and CDC20 are upregulated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
    Kim Y; Choi JW; Lee JH; Kim YS
    Int J Gynecol Pathol; 2014 Sep; 33(5):517-23. PubMed ID: 25083970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
    Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
    Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of astrocyte elevated gene-1 (AEG-1) is associated with progression of cervical intraepithelial neoplasia and unfavorable prognosis in cervical cancer.
    Huang K; Li LA; Meng Y; You Y; Fu X; Song L
    World J Surg Oncol; 2013 Nov; 11():297. PubMed ID: 24256614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
    Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
    Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
    Chen Y; Wang H; Lin W; Shuai P
    Diagn Pathol; 2017 Jan; 12(1):12. PubMed ID: 28109322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
    Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
    Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
    Liu DC; Yang ZL
    Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
    Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y; Liu J; Gong L; Sun X; Long W
    Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
    Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.